OBJECTIVES: To study plasma MMP-9 levels before and after carotid endarterectomy (CEA). DESIGN: Observational study. METHODS: Pre-operative (morning of surgery) and post-operative (48 h) plasma samples were obtained from 75 consecutive patients undergoing CEA. MMP-9 concentrations were quantified using ELISA. Transcranial Doppler monitoring was performed on each patient to detect particulate embolisation during the dissection phase of the CEA, until the application of carotid clamps. RESULTS: The median post-operative plasma MMP-9 level of emboli-positive patients was significantly higher than their median pre-operative value (14.9 ng/ml vs. 8.8 ng/ml; p=0.038). However, no significant difference was seen in the plasma MMP-9 level of emboli-negative patients (7.7 ng/ml vs. 7.1 ng/ml; p=0.364). A greater rise was seen in the median plasma MMP-9 levels of those patients suffering >2 emboli (from 3.4 to 19.3 ng/ml; p=0.041) than those patients suffering 1 or 2 emboli (from 10.1 to 12.8 ng/ml; p=0.340). CONCLUSIONS: Plasma MMP-9 only rises after CEA in patients with evidence of embolisation. This increase is more pronounced in those with high numbers of emboli. These data suggest that the increase in MMP-9 is due to cerebral damage caused by embolisation.
OBJECTIVES: To study plasma MMP-9 levels before and after carotid endarterectomy (CEA). DESIGN: Observational study. METHODS: Pre-operative (morning of surgery) and post-operative (48 h) plasma samples were obtained from 75 consecutive patients undergoing CEA. MMP-9 concentrations were quantified using ELISA. Transcranial Doppler monitoring was performed on each patient to detect particulate embolisation during the dissection phase of the CEA, until the application of carotid clamps. RESULTS: The median post-operative plasma MMP-9 level of emboli-positive patients was significantly higher than their median pre-operative value (14.9 ng/ml vs. 8.8 ng/ml; p=0.038). However, no significant difference was seen in the plasma MMP-9 level of emboli-negative patients (7.7 ng/ml vs. 7.1 ng/ml; p=0.364). A greater rise was seen in the median plasma MMP-9 levels of those patients suffering >2 emboli (from 3.4 to 19.3 ng/ml; p=0.041) than those patients suffering 1 or 2 emboli (from 10.1 to 12.8 ng/ml; p=0.340). CONCLUSIONS: Plasma MMP-9 only rises after CEA in patients with evidence of embolisation. This increase is more pronounced in those with high numbers of emboli. These data suggest that the increase in MMP-9 is due to cerebral damage caused by embolisation.
Authors: Luciene Cristina Figueiredo; Bruno Bueno-Silva; Cristiana Fernandes Plutarco Nogueira; Leonardo Carneiro Valadares; Katia Marina Morilla Garcia; Givelton Coimbra da Luz Filho; Luciano Milanello; Felipe Machado Esteves; Jamil Awad Shibli; Tamires Szeremeske Miranda Journal: Int J Environ Res Public Health Date: 2020-12-06 Impact factor: 3.390
Authors: Bálint Nagy; Gábor Woth; Ákos Mérei; Lilla Nagy; János Lantos; Gábor Menyhei; Lajos Bogár; Diána Mühl Journal: Indian J Med Res Date: 2016-02 Impact factor: 2.375